Published in Mol Cancer on January 27, 2015
OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance. Oncogene (2015) 0.92
OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination. EMBO Mol Med (2016) 0.82
miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1. Am J Cancer Res (2017) 0.78
Erratum: OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo. Mol Cancer (2015) 0.76
DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets. Front Genet (2016) 0.75
The importance of regulatory ubiquitination in cancer and metastasis. Cell Cycle (2017) 0.75
OTUB1 promotes tumor invasion and predicts a poor prognosis in gastric adenocarcinoma. Am J Transl Res (2016) 0.75
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol (2008) 38.00
Integrative genomic profiling of human prostate cancer. Cancer Cell (2010) 23.61
Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res (2011) 14.82
RING domain E3 ubiquitin ligases. Annu Rev Biochem (2009) 12.55
The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell (1995) 9.82
Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol (2009) 8.85
The ubiquitin code. Annu Rev Biochem (2012) 7.08
In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet (1995) 6.60
Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol (2006) 6.25
Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1. Nature (2010) 2.47
DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies. Prostate (2007) 2.37
Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat Struct Mol Biol (2010) 2.31
A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities. Prostate (2011) 2.21
Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J Cell Biol (2007) 2.17
Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem J (2009) 2.12
OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell (2013) 2.05
Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem (2002) 2.01
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy. Cancer Res (2009) 1.71
The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature (2012) 1.70
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc Natl Acad Sci U S A (2008) 1.65
An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains. Nat Struct Mol Biol (2011) 1.55
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Cancer Res (2009) 1.54
Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res (2011) 1.47
Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology (2009) 1.47
Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. EMBO J (2011) 1.38
Quantitative proteomics to study mitogen-activated protein kinases. Methods (2006) 1.26
OTULIN restricts Met1-linked ubiquitination to control innate immune signaling. Mol Cell (2013) 1.25
Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion. FEBS J (2010) 1.23
Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients. Clin Cancer Res (2010) 1.15
Androgen induction of prostate cancer cell invasion is mediated by ezrin. J Biol Chem (2006) 1.12
Fine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choice. Mol Cell (2014) 1.12
A transcription co-factor integrates cell adhesion and motility with the p53 response. Proc Natl Acad Sci U S A (2009) 1.11
E2 ubiquitin-conjugating enzymes regulate the deubiquitinating activity of OTUB1. Nat Struct Mol Biol (2013) 1.10
Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases. Oncogene (2007) 1.05
Ezrin mediates c-Myc actions in prostate cancer cell invasion. Oncogene (2009) 1.04
OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity. J Biol Chem (2009) 1.02
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer. Int J Cancer (2014) 0.95
A20-mediated negative regulation of canonical NF-κB signaling pathway. Immunol Res (2013) 0.93
Androgen receptor gene mutations in hormone-refractory prostate cancer. J Pathol (1999) 0.93
Colon cancer bears overexpression of OTUB1. Pathol Res Pract (2014) 0.91
In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth. Oncogene (2014) 0.88
Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells. Arch Biochem Biophys (1993) 0.85
A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours. Br J Cancer (2014) 0.82
The preventative effects of sunitinib malate observed in the course from non-castration to castration LNCaP xenograft prostate tumors. J Cancer Res Clin Oncol (2012) 0.80
Actin nucleation by a transcription co-factor that links cytoskeletal events with the p53 response. Cell Cycle (2010) 0.80
Polyamines transduce the nongenomic, androgen-induced calcium sensitization in intestinal smooth muscle. Mol Endocrinol (2013) 0.79